In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a AMITRIPTYLINE HCL Drug Master File in Korea (AMITRIPTYLINE HCL KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AMITRIPTYLINE HCL. The MFDS reviews the AMITRIPTYLINE HCL KDMF as part of the drug registration process and uses the information provided in the AMITRIPTYLINE HCL KDMF to evaluate the safety and efficacy of the drug.
After submitting a AMITRIPTYLINE HCL KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AMITRIPTYLINE HCL API can apply through the Korea Drug Master File (KDMF).
click here to find a list of AMITRIPTYLINE HCL suppliers with KDMF on PharmaCompass.